Tivity Health Inc (TVTY) Shares Bought by Two Sigma Advisers LP

Two Sigma Advisers LP increased its position in Tivity Health Inc (NASDAQ:TVTY) by 72.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 299,763 shares of the company’s stock after purchasing an additional 126,400 shares during the quarter. Two Sigma Advisers LP owned approximately 0.76% of Tivity Health worth $10,956,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of TVTY. BlackRock Inc. raised its holdings in Tivity Health by 5.7% in the 4th quarter. BlackRock Inc. now owns 4,624,987 shares of the company’s stock valued at $169,043,000 after acquiring an additional 247,948 shares during the period. Neuberger Berman Group LLC raised its holdings in Tivity Health by 587.7% in the 3rd quarter. Neuberger Berman Group LLC now owns 1,633,016 shares of the company’s stock valued at $66,627,000 after acquiring an additional 1,395,539 shares during the period. American Century Companies Inc. raised its holdings in Tivity Health by 390.7% in the 4th quarter. American Century Companies Inc. now owns 1,238,336 shares of the company’s stock valued at $45,261,000 after acquiring an additional 985,996 shares during the period. Bank of New York Mellon Corp raised its holdings in Tivity Health by 12.7% in the 4th quarter. Bank of New York Mellon Corp now owns 1,194,404 shares of the company’s stock valued at $43,654,000 after acquiring an additional 134,168 shares during the period. Finally, American Capital Management Inc. raised its holdings in Tivity Health by 15.6% in the 4th quarter. American Capital Management Inc. now owns 1,072,823 shares of the company’s stock valued at $39,212,000 after acquiring an additional 144,995 shares during the period.

How to Become a New Pot Stock Millionaire

In other news, CEO Donato Tramuto sold 20,000 shares of the firm’s stock in a transaction that occurred on Thursday, March 1st. The shares were sold at an average price of $38.53, for a total transaction of $770,600.00. Following the transaction, the chief executive officer now directly owns 189,596 shares of the company’s stock, valued at $7,305,133.88. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 8.42% of the stock is currently owned by company insiders.

TVTY has been the topic of several research analyst reports. BidaskClub raised shares of Tivity Health from a “hold” rating to a “buy” rating in a report on Tuesday, March 6th. Zacks Investment Research raised shares of Tivity Health from a “hold” rating to a “buy” rating and set a $44.00 price target on the stock in a report on Thursday, January 25th. Chardan Capital reissued a “neutral” rating and issued a $41.00 price target (down from $44.00) on shares of Tivity Health in a report on Friday, February 23rd. Barrington Research increased their price target on shares of Tivity Health from $40.00 to $47.00 and gave the company an “outperform” rating in a report on Friday, February 23rd. Finally, Cantor Fitzgerald reissued an “overweight” rating and issued a $53.00 price target on shares of Tivity Health in a report on Friday, February 23rd. Two equities research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Tivity Health has a consensus rating of “Buy” and a consensus price target of $46.88.

Tivity Health stock opened at $39.35 on Friday. Tivity Health Inc has a fifty-two week low of $27.30 and a fifty-two week high of $48.50. The company has a market cap of $1,605.31, a P/E ratio of 26.06, a PEG ratio of 1.70 and a beta of 0.27.

Tivity Health (NASDAQ:TVTY) last announced its earnings results on Thursday, February 22nd. The company reported $0.41 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.32 by $0.09. Tivity Health had a net margin of 11.44% and a return on equity of 29.17%. The company had revenue of $139.40 million for the quarter, compared to analysts’ expectations of $138.22 million. During the same period last year, the firm earned $0.35 earnings per share. The business’s revenue for the quarter was up 11.6% on a year-over-year basis. equities analysts predict that Tivity Health Inc will post 2.16 EPS for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “Tivity Health Inc (TVTY) Shares Bought by Two Sigma Advisers LP” was originally reported by Ticker Report and is the sole property of of Ticker Report. If you are reading this article on another site, it was illegally copied and republished in violation of US and international copyright and trademark law. The correct version of this article can be viewed at https://www.tickerreport.com/banking-finance/3299609/tivity-health-inc-tvty-shares-bought-by-two-sigma-advisers-lp.html.

Tivity Health Profile

Tivity Health, Inc, formerly Healthways, Inc, is focused targeted population health for those aged 50 and older. The Company offers three programs: SilverSneakers senior fitness, Prime fitness and WholeHealth Living. The SilverSneakers senior fitness program is offered to members of Medicare Advantage, Medicare Supplement, and Group Retiree plans.

Institutional Ownership by Quarter for Tivity Health (NASDAQ:TVTY)

Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

SunPower  Raised to “Buy” at BidaskClub
SunPower Raised to “Buy” at BidaskClub
FY2018 Earnings Estimate for Kinder Morgan Canada Issued By National Bank Financial
FY2018 Earnings Estimate for Kinder Morgan Canada Issued By National Bank Financial
Yintech Investment  Upgraded by BidaskClub to Hold
Yintech Investment Upgraded by BidaskClub to Hold
NICE Systems  Raised to Strong-Buy at Zacks Investment Research
NICE Systems Raised to Strong-Buy at Zacks Investment Research
Scorpio Bulkers  Cut to Sell at Zacks Investment Research
Scorpio Bulkers Cut to Sell at Zacks Investment Research
Zacks Investment Research Upgrades WesBanco  to Hold
Zacks Investment Research Upgrades WesBanco to Hold


© 2006-2018 Ticker Report. Google+.